Dr. Bishop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Childrens Way FL Wing1
Little Rock, AR 72202Phone+1 501-364-1100Fax+1 501-364-4082
Education & Training
- University of CincinnatiMS, Clinical/Translational Research, 2010 - 2012
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
- Children’s Mercy HospitalResidency, Pediatrics, 2006 - 2009
- University of Arkansas For Medical Sciences College of MedicineClass of 2006
Certifications & Licensure
- AR State Medical License 2024 - 2025
- TN State Medical License 2017 - 2025
- OH State Medical License 2009 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28
- A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
- A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma Start of enrollment: 2017 Feb 16
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsA phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M. Federico, Alberto S. Pappo, Natasha Sahr, April Sykes, Olivia Campagne
European Journal of Cancer. 2020-09-01 - 80 citationsProvocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology GroupRyan D. Roberts, Michael M. Lizardo, Damon R. Reed, Pooja Hingorani, Jason Glover
Cancer. 2019-10-15 - 134 citationsPremature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.Wassim Chemaitilly, Zhenghong Li, Matthew J. Krasin, Russell J. Brooke, Carmen L. Wilson
The Journal of Clinical Endocrinology and Metabolism. 2017-07-01
Journal Articles
- Serum ALT Elevations in Survivors of Childhood Cancer. A Report from the St. Jude Lifetime Cohort StudyMatthew J Krasin, Sima Jeha, Daniel M Green, Melissa M Hudson, Wayne L Furman, Michael W Bishop, Hepatology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: